| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 98555-04-5 | thiocyanic acid, p-ureidophenyl ester | |
| |
| 98551-71-4 | glycine, n,n-bis(2-chloroethyl)-, ethyl ester, n-oxide, hydrochloride | |
| |
| 98551-69-0 | n,n-bis(2-chloroethyl)glycine ethyl ester hydrochloride | |
| |
| 98550-30-2 | cyano-acetic aci 2-(5-nitro-2-furyl)hydrazide | |
| |
| 98550-17-5 | 2,1,3-benzothiadiazole-5-carbohydrazide | |
C7H6N4OS | |
| 98546-65-7 | 5-bromo-3-ethyl-1-penten-4-yn-3-o | |
| |
| 98546-51-1 | 4-甲硫基苯硼酸
4-(Methylthio)benzeneboronic acid | 熔点：210-214℃
|
C7H9BO2S | 168.0169 |
| 98541-64-1 | butoxycarbonylserinebetalactone | 沸点：319°C
|
C8H13NO4 | 187.19 |
| 98540-87-5 | n-cyclohexyl-n'-(1-pyrenyl) carbodiimide | |
| |
| 98537-27-0 | u 23469-boronated | |
| |
| 98534-81-7 | 1-Phenyl-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid | 密度：1.338 g/cm3
熔点：136-139℃
沸点：138.5 °C at 760mmHg
|
C11H7F3N2O2 | 256.19 |
| 98534-80-6 | 2-(4-chlorophenyl)-3-(trifluoromethyl)pyrazole- 4-carboxylic acid | 密度：1.56±0.1 g/cm3(Predicted)
熔点：160-164℃
沸点：392.9±42.0 °C(Predicted)
|
C11H6F3N2O2 | 255.17 |
| 98534-25-9 | 1-(4-chlorophenyl)-n-methyl-5-(trifluoromethyl)-1h-pyrazole-4-carboxamid | |
| |
| 98534-22-6 | 1-(2,4-dichlorophenyl)-n-methyl-5-(trifluoromethyl)-1h-pyrazole-4-carboxamid | |
| |
| 98534-15-7 | 5-chloro-1-(1,1-dimethylethyl)-n-methyl-1h-pyrazole-4-carboxamid | |
| |
| 98533-68-7 | 1-(4-bromophenyl)-5-chloro-n-methyl-1h-pyrazole-4-carboxamid | |
| |
| 98533-60-9 | 5-chloro-1-(4-fluorophenyl)-n-methyl-1h-pyrazole-4-carboxamid | |
| |
| 98533-44-9 | 5-bromo-1-(3-fluorophenyl)-n-methyl-1h-pyrazole-4-carboxamid | |
| |
| 98533-16-5 | 5-chloro-1-(3-chlorophenyl)-n-methyl-1h-pyrazole-4-carboxamid | |
| |
| 98532-86-6 | cis-n-2-yl) methyl) | |
| |
| 98532-85-5 | 1h-1,2,4-triazole, 1-((2-(2-benzofuranyl)-5-ethyl-4-propyl-1,3-dioxan-2-yl)meth | |
| |
| 98532-84-4 | 2,4-cis-1-((2-(2-benzofuranyl)-5-butyl-5-ethyl-3-dioxan-2-yl)methyl)-1h-1 | |
| |
| 98532-83-3 | 2,4-triazole, 1-(2-(2-benzofuranyl)-4-methyl-1,3-dioxan-2-yl)methyl)-1h- cis | |
| |
| 98532-82-2 | cis-l) | |
| |
| 98532-81-1 | 4-triazole, 1-((2-(2-benzofuranyl)-5,5-diethyl-1,3-dioxan-2-yl)methyl)-1h-2 | |
| |
| 98532-80-0 | cis-)methyl) | |
| |
| 98532-79-7 | cis-1-((2-(2-benzofuranyl)-5-methyl-5-propyl-1,3-dioxan-2-yl)methyl)-1h- 1,2, | |
| |
| 98532-78-6 | cis-1-((2-(2-benzofuranyl)-5-ethyl-5-methyl-1,3-dioxan-2-yl)methyl)-1h-1 ,2,4 | |
| |
| 98532-77-5 | 4-triazole, 1-((2-(5,7-dichloro-2-benzofuranyl)-5,5-dimethyl-1,3-dioxan-1h-2 | |
| |
| 98532-76-4 | nitrat von 2-(benzofuran-2-yl)-2-(1-(1h-1,2,4-triazolyl)-methyl)-5,5-dimethyl | |
| |
| 98532-75-3 | 4-triazole, 1-((2-(2-benzofuranyl)-5,5-dimethyl-1,3-dioxan-2-yl)methyl)-1h-2 | |
| |
| 98532-74-2 | 1h-1,2,4-triazole, 1-((2-(2-benzofuranyl)-4,5-dimethyl-1,3-dioxolan-2-yl)methyl | |
| |
| 98532-73-1 | cis-xolan-2-yl) methyl) | |
| |
| 98532-72-0 | cis-1-((2-(2-benzofuranyl)-4-(phenoxymethyl)-1,3-dioxolan-2-yl)methyl)-1 h-1, | |
| |
| 98532-71-9 | cis 1-((2-(2-benzofuranyl)-4-(ethoxymethyl)-1,3-dioxolan-2-yl)methyl)-1h-1,2 | |
| |
| 98532-70-8 | cis-l)- | |
| |
| 98532-69-5 | 1h-1,2,4-triazole, 1-((2-(5,7-dimethoxy-2-benzofuranyl)-1,3-dioxolan-2-yl)methy | |
| |
| 98532-68-4 | cis-yl) methyl) | |
| |
| 98532-67-3 | 1h-1,2,4-triazole, 1-((2-(5,7-dichloro-2-benzofuranyl)-1,3-dioxolan-2-yl)methyl | |
| |
| 98532-66-2 | cis-l) methyl) | |
| |
| 98532-65-1 | 4-triazole, 1-((2-(2-benzofuranyl)-1,3-dioxolan-2-yl)methyl)-1h-2 | |
| |
| 98532-64-0 | cis-1-((2-(2-benzofuranyl)-4-(methoxymethyl)-1,3-dioxolan-2-yl)methyl)-1 h-1, | |
| |
| 98532-13-9 | dl-aspartic-2-13c-15n acid | |
| |
| 98532-00-4 | 1-aminooxy-3-aminopropane | |
| |
| 98530-28-0 | neuromedin u 25 | |
| |
| 98530-27-9 | neuromedin u 8 | |
| |
| 98530-19-9 | lr gold | |
| |
| 98530-12-2 | interferon-alpha-2 (human leucocyte clone pm21 protein moiety reduced) | |
| |
| 98527-38-9 | 1,2-ethanediol, nonanoate, octadecanoa te | |
| |
| 98527-06-1 | benzamide, 3-bromo-5-ethyl-n-((1-ethyl-2-pyrrolidinyl)methyl)-6-hydroxy-2-metho | |
| |
